Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kume, A.
Right arrow Articles by Ozawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kume, A.
Right arrow Articles by Ozawa, K.
Stem Cells, Vol. 17, No. 4, 226-232, July 1999
© 1999 AlphaMed Press

Green Fluorescent Protein as a Selectable Marker of Retrovirally Transduced Hematopoietic Progenitors

Akihiro Kumea, Motohiro Hashiyamab, Toshio Sudab, Keiya Ozawaa,c

a Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan;
b Department of Cell Differentiation, Institute of Molecular Genetics and Embryology, Kumamoto University School of Medicine, Kumamoto, Japan;
c Department of Hematology, Jichi Medical School, Tochigi, Japan

Key Words. Gene therapy • Green fluorescent protein • Hematopoietic progenitor • Retrovirus vector • Selectable marker • Flow cytometry

Dr. Akihiro Kume, Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi-machi, Kawachi-gun, Tochigi 329-0498, Japan.

Recombinant retroviruses are most commonly used in hematopoietic stem cell gene therapy trials, but gene transfer efficiency is still inadequate with the present vectors. One approach for overcoming this problem is to develop methods of selecting and enriching the successfully transduced cells. We investigated the feasibility of using the green fluorescent protein (GFP) gene as a selectable marker of hematopoietic cells. When M1 murine leukemia cells were electroporated with GFP expression vectors, a red-shifted mutant (S65T) GFP showed several-fold greater fluorescence than the wild-type GFP and generated readily detectable green light under control of SRa or CAG promoter. We then inserted an SRa-S65T GFP cassette into the MSCV retrovirus vector and established virus producer cells. Infection of primary murine bone marrow cells resulted in a distinct population with green fluorescence, which was separated by fluorescence-activated cell sorting. The fractionated bright cells gave rise to fluorescent spleen colonies in lethally irradiated mice, while the fluorescence-negative cells yielded only dark colonies. These results indicated that GFP is a faithful marker in gene transfer into hematopoietic progenitor/stem cells, facilitating selection of the transduced cells and tracking of their progeny in vivo. Stem Cells 1999;17:226-232




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
J.-C. Tseng, B. Levin, T. Hirano, H. Yee, C. Pampeno, and D. Meruelo
In Vivo Antitumor Activity of Sindbis Viral Vectors
J Natl Cancer Inst, December 4, 2002; 94(23): 1790 - 1802.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Arima, H. Toyama, H. Ichii, S. Kojima, S. Okada, M. Hatano, G. Cheng, M. Kubo, T. Fukuda, and T. Tokuhisa
A Putative Silencer Element in the IL-5 Gene Recognized by Bcl6
J. Immunol., July 15, 2002; 169(2): 829 - 836.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 1999 by AlphaMed Press.